Loading...
Please wait, while we are loading the content...
Similar Documents
Compounds, Compositions, and Methods for The Treatment of Cancers
| Content Provider | The Lens |
|---|---|
| Abstract | The present teachings relate to compounds and compositions for treatment of cancers. In some embodiments, the composition comprises a platinum (IV) complex having at least one carboxylate or carbamate ligand. |
| Related Links | https://www.lens.org/images/patent/012-771-160-063-520/pdf/US_2017_A1_20170087118_012-771-160-063-520.pdf |
| Language | English |
| Publisher Date | 2019-01-17 |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Patent |
| Jurisdiction | United States of America |
| Date Applied | 2018-09-19 |
| Applicant | Placon Therapeutics Inc |
| Application No. | 201816135791 |
| Claim | A compound of Formula I, or a pharmaceutically acceptable salt thereof, wherein: two of R 1 , R 2 , R 3 , and R 4 each is a halide; the remaining two of R 1 , R 2 , R 3 , and R 4 each is independently ammonia or an amine; and R 5 and R 6 each independently is hydrogen, R 7 , or wherein: X is absent, C(R 8 ) 2 , O, S, or NR 8 , and R 7 and R 8 independently at each occurrence is selected from hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, and heteroaryl, wherein each of the alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, and heteroaryl groups optionally is substituted with one or more groups, each independently selected from halogen, cyano, nitro, hydroxyl, ester, ether, alkoxy, aryloxy, amino, amide, carbamate, alkyl, alkenyl, alkynyl, aryl, arylalkyl, cycloalkyl, heteroaryl, heterocyclyl, phosphono, phosphate, sulfide, sulfinyl, sulfino, sulfonyl, sulfo, and sulfonamide, wherein each of the ester, ether, alkoxy, aryloxy, amino, amide, carbamate, alkyl, alkenyl, alkynyl, aryl, arylalkyl, cycloalkyl, heteroaryl, heterocyclyl, phosphono, phosphate, sulfide, sulfinyl, sulfino, sulfonyl, sulfo, and sulfonamide is optionally substituted with one or more suitable substituents. The compound of claim 1 , wherein two of R 1 , R 2 , R 3 , and R 4 each is a halide. The compound of claim 1 , wherein two of R 1 , R 2 , R 3 , and R 4 each is C The compound of claim 1 , wherein the remaining two of R 1 , R 2 , R 3 , and R 4 each is ammonia. The compound of claim 1 , wherein at least one of the remaining two of R 1 , R 2 , R 3 , and R 4 is an amine. The compound of claim 1 , wherein the remaining two of R 1 , R 2 , R 3 , and R 4 joined together form a diamine. The compound of claim 1 , wherein the remaining two of R 1 , R 2 , R 3 , and R 4 joined together form cyclohexane-1,2-diamine. The compound of claim 1 , wherein at least one of R 5 and R 6 is and X is C(R 8 ) 2 . The compound of claim 1 , wherein R 5 and R 6 are different. and X is NR 8 . The compound of claim 1 , wherein R 7 is alkyl or cycloalky The compound of claim 1 , wherein R 7 is alkyl optionally substituted with one or more groups each independently selected from halogen, hydroxyl, ester, alkoxy, aryloxy, amino, amide, aryl, arylalkyl, cycloalkyl, heteroaryl, and heterocyclyl, wherein each of ester, alkoxy, aryloxy, amino, amide, aryl, arylalkyl, cycloalkyl, heteroaryl, and heterocyclyl optionally is substituted with one or more suitable substituents. The compound of claim 12 , wherein R 7 is alkyl optionally substituted with one or more groups each independently selected from halogen, hydroxyl, alkoxy, aryloxy, arylalkoxy, amino, amide, and aryl, wherein each of alkoxy, aryloxy, arylalkoxy, amino, amide, and aryl optionally is substituted with one or more substituents, each independently selected from one or more suitable substituents. The compound of claim 13 , wherein R 7 is alkyl optionally substituted with one or more groups each independently selected from F, Cl, phenyl, benzyloxy, t-butylphenyl, amino, and bistrifluoromethylpheny The compound of claim 1 , wherein at least one of R 5 and R 6 is R 7 . The compound of claim 1 , wherein R 7 is a monocycloalkyl, a bicycloalkyl, or a tricycloalky The compound of claim 16 , wherein R 7 is cycloheptyl, cyclooctyl, cyclopentyl, cyclodecanyl, cycloundecanyl, cyclododecanyl, or adamanty A compound selected from: A pharmaceutical composition comprising a compound according to claim 1 . The pharmaceutical composition of claim 19 comprising a particle. The pharmaceutical composition of claim 20 , wherein the particle comprises polyester. The pharmaceutical composition of claim 19 comprising a surfactant. The pharmaceutical composition of claim 19 comprising a lyoprotectant. The pharmaceutical composition of claim 19 , wherein less than 50% of the compound is released in the first hour. A method of treating cancer selected from lung cancer, breast cancer, colorectal cancer, ovarian cancer, bladder cancer, prostate cancer, cervical cancer, renal cancer, leukemia, central nervous system cancers, myeloma, and melanoma, comprising administering a therapeutically effective amount of a compound of claim 1 . A method of inhibiting proliferation of a cell comprising contacting the cell with an effective amount of a compound of claim 1 . The method of claim 26 , wherein the cell is a cancer cel |
| CPC Classification | Preparations For Medical; Dental Or Toiletry Purposes Specific Therapeutic Activity Of Chemical Compounds Or Medicinal Preparations ACYCLIC; CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON; HYDROGEN; HALOGEN; OXYGEN; NITROGEN; SULFUR; SELENIUM OR TELLURIUM TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION |
| Extended Family | 012-771-160-063-520 056-025-282-104-070 097-620-441-425-335 095-157-389-975-756 038-708-102-752-805 144-158-631-436-217 |
| Patent ID | 20190015378 |
| Inventor/Author | Bilodeau Mark T Dunbar Craig A Barder Timothy E Lee Edward R Alargova Rossitza G Rockwood Danielle N Shinde Rajesh R Lim Soo Patrick Moreau Benoît |
| IPC | A61K31/282 A61K9/00 A61K9/08 A61K9/51 A61K47/26 A61K47/34 C07F15/00 |
| Status | Discontinued |
| Owner | Placon Therapeutics Inc Xlink Therapeutics Inc Blend Therapeutics Inc |
| Simple Family | 012-771-160-063-520 095-157-389-975-756 097-620-441-425-335 056-025-282-104-070 038-708-102-752-805 144-158-631-436-217 |
| CPC (with Group) | A61K31/282 A61P35/00 C07F15/0093 Y10T428/298 A61K9/0019 A61K9/08 A61K9/5153 A61K47/26 A61K47/34 |
| Issuing Authority | United States Patent and Trademark Office (USPTO) |
| Kind | Patent Application Publication |
